Advance your lead peptide candidates from discovery to market
Peptide therapeutics, encompassing a range of synthetic and recombinantly created peptides, including GLP-1 recombinant analogs, represent a rapidly advancing frontier in pharmaceutical development for a range of conditions. Due to their structural complexity, susceptibility to degradation, and the presence of multiple possible contaminants like residual solvents and synthesis by-products, analyzing peptides can be challenging. Advanced analytical techniques such as mass spectrometry and high-performance liquid chromatography (HPLC) are essential for accurate analysis. Agilent supports your therapeutic peptide development with seamless characterization workflows, effortless integration, and expert guidance
Complete Your Journey to Therapeutic Success
End-to-end solutions and support to bridge every gap in your GLP-1 receptor agonists and peptide characterizations
Download our application compendium and Workflow resource guide.